Results 81 to 90 of about 3,045,581 (181)

NUDT15 and TPMT Pharmacogenomic Testing for Azathioprine‐Induced Adverse Reactions in Immune‐Mediated Skin Diseases

open access: yesDermatologic Therapy, Volume 2026, Issue 1, 2026.
Background While thiopurine S‐methyltransferase (TPMT) variants are known to correlate with azathioprine (AZA)‐induced adverse effects (AEs), nucleoside diphosphate‐linked moiety X Motif 15 (NUDT15) variants were reported to be more prevalent and correlated with AZA toxicity in Asians.
Koramon Phuwaraks   +10 more
wiley   +1 more source

Treatment of linear IgA bullous dermatosis of childhood with flucloxacillin

open access: yes, 2006
Linear IgA bullous dermatosis of childhood is a rare autoimmune bullous disease that mainly affects preschool-aged children. Dapsone is considered the first-line therapy with prompt response from most patients.
Al-Rasheed, Saleh   +6 more
core  

Drug-induced linear IgA bullous dermatosis

open access: yesDermatology Online Journal, 2006
A 73-year-old man was admitted to the University of California Davis Medical Center for treatment of a pleural effusion and congestive heart failure. His hospital course was complicated by asymptomatic sustained ventricular tachycardia requiring placement of an implantable cardiac defibrillator.
Navi, Daniel   +2 more
openaire   +4 more sources

Linear IgA bullous dermatosis in a child successfully responding to oral antibiotics

open access: yes, 2018
Linear IgA bullous dermatosis (LABD) is a rare, chronic, autoimmune bullous dermatosis affecting young children and adults. The exact pathogenesis of this disease is still unknown, although both humoral and cellular immune response are involved ...
G Senhaji*   +7 more
core   +1 more source

Diagnosing linear immunoglobulin - A dermatosis of childhood in a resource-constrained area: Case report and review of literature

open access: yesSahel Medical Journal, 2013
Linear immunoglobulin A (IgA) dermatosis (LAD) of childhood is a self-limiting blistering eruption. At histology, the blisters are subepidermal and may be reported as resembling dermatitis herpetiformis or bullous pemphigoid.
Muhammad S Mijinyawa   +3 more
doaj   +1 more source

Linear IgA bullous dermatosis in a 4-year-old child

open access: yesDermatology Reports
Dear Editor, Linear IgA bullous dermatosis (LABD) is the most common autoimmune blistering disease in childhood, though it remains rare. It is characterized by tense blisters and vesicles, often in a rosette or “string of pearls” pattern, predominantly ...
Filomena Barbato   +6 more
doaj   +1 more source

Generalized linear IgA dermatosis with palmar involvement [PDF]

open access: yes, 2015
Linear IgA bullous dermatosis (LABD) is a sub-epidermal blistering disorder characterized by deposition of IgA along the basement membrane zone (BMZ) as detected by immunofluorescence microscopy.
Malone, Janine C   +3 more
core   +1 more source

Localized Linear IgA/IgG Bullous Dermatosis

open access: yesActa Dermato Venereologica, 2010
Linear IgA/IgG bullous dermatosis (LAGBD) is an auto-immune blistering disease characterized by the local accumulation of IgA- and IgG-class anti-basement membrane autoantibodies. It typically presents as a generalized pruritic vesiculobullous eruption. No cases of localized LAGBD have yet been reported. We report a case of a 78-year-old man with LAGBD
Satoko, Shimizu   +5 more
openaire   +3 more sources

Unmasking The Blisters: A Case Of Pediatric Linear IGA Bullous Dermatosis Mimicking Bullous Impetigo [PDF]

open access: yes
Introduction – Linear IgA bullous dermatosis (LABD) is one of many diseases that fall under the umbrella of bullous diseases. It is a rare and chronic autoimmune condition affecting both adult and pediatric populations.
Raza Ali, Mir   +4 more
core   +1 more source

Linear IgA bullous dermatosis induced by atezolizumab: a case report

open access: yesDermatology Reports
Linear IgA Bullous Dermatosis (LABD) is a rare immune-mediated vesiculobullous disease that was reported to be induced by infections or medications. Atezolizumab is a monoclonal antibody targeting programmed cell death ligand-1 (PD-L1), it has been used
Seba Almutairi, Dana Alessa
doaj   +1 more source

Home - About - Disclaimer - Privacy